nach oben

Erschienen in:

01.12.2014 | Metabolism (R Pasquali, Section Editor)

Predictors of Ectopic Fat in Humans

verfasst von: Mauro Zamboni, Andrea P Rossi, Francesco Fantin, Simona L Budui, Elena Zoico, Giulia A Zamboni, Gloria Mazzali

Erschienen in: Current Obesity Reports | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

In the last decade there has been increasing focus on body fat distribution, rather than on the degree of obesity. More recently, great interest has also been dedicated to ectopic fat deposition in overnourished individuals that reflects a failure of the system of intracellular lipid homeostasis, which, in normal conditions, prevents lipotoxicity in the organs, by confining lipid overload to cells specifically designed to store large quantities of surplus calories, the white adipocytes. Consequently, excess body weight leads to fat infiltration of multiple organs including liver, pancreas, skeletal muscle, and heart thus forming “ectopic fat”. Although overfeeding is considered the main predictor of ectopic fat deposition, other factors may be also involved. The purpose of this review is to evaluate the current available data on the predictors of ectopic fat deposition in humans.

Virtue S, Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. PLoS Biol. 2008;6(9):e237.PubMedCentralPubMed

Bjorntorp P, Bengtsson C, Blohmé G, et al. Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women. Metabolism. 1971;20:927–35.PubMed

Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–7.PubMed

Araki S, Okazaki M, Goto S. Impaired lipid metabolism in aged mice as revealed by fasting-induced expression of apolipoprotein mRNAs in the liver and changes in serum lipids. Gerontology. 2004;50:206–15.PubMed

Ferland M, Després J-P, Tremblay A, et al. Assessment of adipose tissue distribution by computer axial tomography in obese women: association with body density and anthropometric measurements. Brit J Nutr. 1989;61:139–48.PubMed

6.•

Alligier M, Meugnier E, Deebard S, et al. Subcutaneous adipose tissue remodelling during the initial phase of weight gain induced by overfeeding in humans. J Clin Endocrinol Metab. 2012;97:E183–92. Using bioptic samples of subcutaneous abdominal AT from forty-four healthy men on lipid-enriched diet (+760kcal/day for 2months), this study demonstrated a reorganization of gene expression occurred in AT with an up-regulation of numerous genes involved in lipid metabolism and storage, followed by clusters of genes related to angiogenesis and extracellular matrix remodelling. Moreover, biopsies’ histological examination showed increased microvascular density and connective tissue deposition after 56 days of overfeeding, with no changes in the number of inflammatory cells. Additionally, it had been suggested that the inhibition of the WNT/beta-catenin signalling pathway and the induction of the rennin-angiotensin system might be implicated in the remodelling of the subcutaneous AT.PubMed

Ross R, Fortier L, Hudson R. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women. Diabetes Care. 1996;19:1404–11.PubMed

Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570–8.PubMed

McQuaid SE, Hodson L, Neville MJ, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes. 2011;60(1):47–55.PubMedCentralPubMed

10.•

Ichimura A, Hirasawa A, Poulain-Godefroy O, et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature. 2012;483:350–4. This study investigated the role of GPR120 (G-protein-coupled receptors 120), a receptor for unsaturated long-chain FFA, in various physiological mechanism such as adipogensis, regulation of appetite and food preference. It was demonstrated that GPR120-deficient mice fed with a high-fat diet developed obesity, glucose intolerance and fatty liver, decreased adipocyte differentiation and lipogenesis, and enhanced hepatic lipogenesis. In human subjects, GPR120 expression in AT was significantly higher in obese individuals than in lean controls, while GPR120 exon sequencing in obese subjects revealed a deleterious non-synonymous mutation (p.R270H) that inhibits GPR120 signalling activity. Moreover, it seems that p.R270H variant increases obesity risk in European population.PubMed

11.

Gallagher D, Kuznia P, Heshka S, et al. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr. 2005;81(4):903–10.PubMedCentralPubMed

12.

Rossi A, Zoico E, Goodpaster BH, et al. Quantification of intermuscular adipose tissue in the erector spinae muscle by MRI: agreement with histological evaluation. Obesity. 2010;18:2379–84.PubMed

13.

Korach-André M, Guo J, Gounarides JS, Deacon R, Islam A, Laurent D. Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance. Am J Physiol Endocrinoil Metab. 2005;288:E106–16.

14.

Kleiner DE, Brunt EM. Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research. Semin Liver Dis. 2012;32:3–13.PubMed

15.

Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106:171–6.PubMedCentralPubMed

16.

Rossi AP, Fantin F, Zamboni G, et al. Predictors of ectopic fat deposition in liver and pancreas in obese men and women. Obesity. 2011;19:1747–54.PubMed

17.

Machann J, Thamer C, Schnoedt B, et al. Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI/MRS study. Magma. 2005;18:128–37.PubMed

18.

Nielsen S, Guo Z, Johnson M, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest. 2004;11:1582–8.

19.

Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343–51.PubMedCentralPubMed

20.

Pinnick KE, Collins SC, Londos C, et al. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity. 2008;16:522–30.PubMed

21.

Mathur A, Marine M, Lu D, et al. Nonalcoholic fatty pancreas disease. HPB. 2007;9:312–8.PubMedCentralPubMed

22.

Toledo-Corral CM. Ectopic fat deposition in prediabetic overweight and obese minority adolescents. J Clin Endocrinol Metab. 2013;98:1115–21.PubMedCentralPubMed

23.

Sharma S, Adrogue JV, Golfman L, et al. Intramyocellular lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004;18:1692–700.PubMed

24.

Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy. Am J Physiol. 2003;276:E977–89.

25.

Baroldi G, Silver MD, De Maria R, Parodi O, Pellegrini A. Lipomatous metaplasia in left ventricular scar. Can J Cardiol. 1997;13:65–71.PubMed

26.

Su L, Siegel JE, Fishbein MC. Adipose tissue in myocardial infarction. Cardiovasc Pathol. 2004;13:98–102.PubMed

27.

Unger RH, Clark GO, Scherer PE, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta. 1801;2010:209–14.

28.

Gambarino J, Sturley SL. Saturated with fat: new perspectives on lipotoxicity. Curr Opin Clin Nutr Metab Care. 2009;12:110–6.

29.

Tovar AR, Torres N. The role of dietary protein on lipotoxicity. Biochim Biophys Acta. 1801;2010:367–71.

30.

Corcoran MP, Lamon-Fava S, Fielding RA. Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. Am J Clin Nutr. 2007;85:662–77.PubMed

31.

Delarue J, LeFoll C, Corporeau C, Lucas D. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev. 2004;44:289–99.PubMed

32.

D'Alessandro ME, Chicco A, Lombardo YB. Fish oil reverses the altered glucose transporter, phosphorylation, insulin receptor substrate-1 protein level and lipid contents in the skeletal muscle of sucrose-rich diet fed rats. Prostaglandins Leukot Essent Fat Acids. 2013;88:171–7.

33.

Lê KA, Faeh D, Stettler R, et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr. 2006;84:1374–9.PubMed

34.

Westerbacka J, Lammi K, Häkkinen AM, et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab. 2005;90:2804–9.PubMed

35.

Rosqvist F, Iggman D, Kullberg J, et al. Overfeeding Polyunsaturated and Saturated Fat Causes Distinct Effects on Liver and Visceral Fat Accumulation in Humans. Diabetes. 2014. doi:10.2337/db13-1622.PubMed

36.

Mollard RC, Sénéchal M, Macintosh AC, et al. Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes. Am J Clin Nutr. 2014;99:804–12.PubMed

37.

Clarke SD, Gasperikova D, Nelson C, Lapillonne A, Heird WC. Fatty acid regulation of gene expression: a genomic explanation for the benefits of the mediterranean diet. Ann N Y Acad Sci. 2002;967:283–98.PubMed

38.

Tappy L, Lê KA. Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin Res Hepatol Gastroenterol. 2012;36:554–60.PubMed

39.

Lê KA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009;89:1760–5.PubMed

40.

Bortolotti M, Kreis R, Debard C, et al. High protein intake reduces intrahepatocellular lipid deposition in humans. Am J Clin Nutr. 2009;90:1002–10.PubMed

41.•

Drosatos K, Schulze PC. Cardiac lipotoxicity: molecular pathways and therapeutic implications. Curr Heart Fail Rep. 2013;10:109–21. An overview of the current literature that synthesised the deleterious effect of lipotoxicity on cardiac diseases’ pathogenesis. Lipotoxicity may be the result of a toxic metabolic shift to more FA and less glucose oxidation with concomitant accumulation of toxic lipids, as fatty acyl coenzyme A, DAG, and ceramide, which could directly alter cellular structures and may cause apoptosis, defective insulin signalling, endoplasmatic stress, activation of protein kinase C, MAPK activation, or modulation of PPARs. All these aspects confirm the fact that lipotoxicity have become a public health concern and is responsible for a significant portion of clinical cardiac disease.PubMedCentralPubMed

42.

Wende AR, Abel ED. Lipotoxicity in the heart. Biochim Biophys Acta. 1801;2010:311–9.

43.

Torre-Villalvazo I, Gonzalez F, Aguilar-Salinas CA, Tovar AR, Torres N. Dietary soy protein reduces cardiac lipid accumulation and the ceramide concentration in high-fat diet-fed rats and ob/ob mice. J Nutr. 2009;139:2237–43.PubMed

44.

Estruch R, Ros E, Salas-Salvadó J, et al. PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279–90.PubMed

45.

Ryan MC, Itsiopoulos C, Thodis T, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59:138–43.PubMed

46.•

Trovato FM, Catalano D, Martines GF, Pace P, Trovato GM. Mediterranean diet and non-alcoholic fatty liver disease.: The need of extended and comprehensive interventions. Clin Nutr. 2014. doi:10.1016/j.clnu.2014.01.018. This study proves that the adherence to the Mediterranean Diet is a significant predictor of changes in liver’s fat content in overweight patients with NAFLD. The effect of the diet was gradual and was registered after 6 months of intervention, independently of other lifestyle changes.PubMed

47.

Corella D, Ordovás JM. How does the Mediterranean diet promote cardiovascular health? Current progress toward molecular mechanisms: Gene-diet interactions at the genomic, transcriptomic, and epigenomic levels provide novel insights into new mechanisms. Bioessays. 2014;36:526–37.PubMed

48.

Schrauwen-Hinderling VB, Hesselink MK, Schrauwen P, Kooi ME. Intramyocellular lipid content in human skeletal muscle. Obesity. 2006;14:357–67.PubMed

49.

Leskinen T, Sipilä S, Alen M, et al. Leisure-time physical activity and high-risk fat: a longitudinal population-based twin study. Int J Obes. 2009;33:1211–8.

50.

Leskinen T, Sipilä S, Kaprio J, et al. Physically active vs. inactive lifestyle, muscle properties, and glucose homeostasis in middle-aged and older twins. Age. 2013;35:1917–26.PubMedCentralPubMed

51.

Perseghin G, Lattuada G, De Cobelli F, et al. Habitual physical activity level is associated with intrahepatic fat content. Diabetes Care. 2007;30:683–8.PubMed

52.

Viljanen AP, Iozzo P, Borra R, et al. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. J CLin Endocrinol Metab. 2009;94:50–5.PubMed

53.

Hannukainen JC, Borra R, Lindeborg K, et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins discordant for physical activity. J Hepatol. 2011;54:545–52.PubMed

54.

Bacchi E, Negri C, Targher G, et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease. Hepatology. 2013;58:1287–95.PubMed

55.

Sarma S, Carrick-Ranson G, Fujimoto N, et al. Effects of age and aerobic fitness on myocardial lipid content. Circ Cardiovasc Imaging. 2013;6:1048–55.PubMedCentralPubMed

56.

Jonker JT, de Mol P, de Vries ST, et al. Exercise and type 2 diabetes mellitus: changes in tissue-specific fat distribution and cardiac function. Radiology. 2013;269(2):434–42.PubMed

57.

Sai E, Shimada K, Yokoyama T, et al. Association between myocardial triglyceride content and cardiac function in healthy subjects and endurance athletes. PLoS ONE. 2013;16(8):e61604.

58.

Bucher J, Krüsi M, Zueger T, et al. The effect of a single 2 h bout of aerobic exercise on ectopic lipids in skeletal muscle, liver and the myocardium. Diabetologia. 2014;57:1001–5.PubMed

59.

Stanley TL, Grinspoon SK. Body composition and metabolic changes in HIV-infected patients. JID. 2012;205(suppl3):s383–90.PubMedCentralPubMed

60.

Guaraldi G, Stentarelli C, Zona S, Santoro A. HIV-associated lipodystrophy: impact of anti-retroviral therapy. Drugs. 2013;73(13):1431–50.PubMed

61.

Torriani M, Hadigan C, Jensen ME, Grinspoon S. Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with HIV-lipidystrophy syndrome. J Appl Physiol. 2003;95(3):1005–10.PubMed

62.

Hadigan C, Liebau J, Andersen R, Holalkere NS, Sahani DV. Magnetic resonance spectroscopy of hepatic lipid content and associated risk factors in HIV infection. J Acquir Immune Defic Syndr. 2007;46(3):312–7.PubMed

63.

Kim RJ, Wilson CG, Wabitsch M, Lazar MA, Steppan CM. HIV protease-inhibitor-specific alterations in human adipocytes differentiation and metabolism. Obes (Silver Spring). 2006;14(6):994–1002.

64.

Nolan D, Hammond E, Martin A, et al. Mitochondrial DNA depletion and morphological changes in adipocytes associated with nucleoside reverse trascriptase inhibitor therapy. AIDS. 2003;17(9):1329–38.PubMed

65.

Andersen O, Pedersen SB, Svenstrup B, et al. Circulating sex hormones and genes expression of subcutaneous adipose tissue oestrogen and plasma alpha-adrenergic receptors in HIV-lipodystroph: implications for fat distribution. Clin Endocrinol. 2007;67(2):250–8.

66.

Barzon L, Zamboni M, Pacenti M, et al. Do estrogens receptors play a role in the pathogenesis of HIV-associated lipodystrophy. AIDS. 2005;19:531–3.PubMed

67.

Anderson LA, McTernan PG, Barnett AH, Kumar S. The effects of androgens and estrogens on pre-adipocytes proliferation in human adipose tissue: influence of gender and site. J Clin Endocrinol Metab. 2001;86(10):5045–51.PubMed

68.

Hazlehurst JM, Tomlinson JW. Non-alcoholic fatty liver disease in common endocrine disorders. Eur J Endocrinol. 2013;169(2):R27–37.PubMed

69.•

Camporez JP, Jornayvaz FR, Lee HY, et al. Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet induced hepatic and muscle insulin resistance. Endocrinology. 2013;154(3):1021–8. These study demonstrated that estradiol plays a pivotal role in the regulation of whole-body energy homeostasis, increasing O2 consumption and energy expenditure in ovariectomized mice, and in turn preventing diet-induced ectopic lipid deposition and hepatic and muscle insulin resistance.PubMedCentralPubMed

70.

Koutkia P, Eaton K, You SM, Breu J, Grinspoon S. Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution. AIDS. 2006;20(6):855–62.PubMed

71.

Chaves VE, Junior FM, Bertolini GL. The metabolic effects of growth hormone in adipose tissue. Endocrine. 2013;44(2):293–302.PubMed

72.

Sprung VS, Jones H, Pugh CJ, et al. Endothelial dysfunction in hyperandrogenic polycyctic ovary syndrome is not explained by either obesity or ectopic fat deposition. Clin Sci. 2014;126(1):67–74.PubMed

73.•

Jones H, Sprung VS, Pugh CJ, et al. Polysystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to non-hyperandrogenic PCOS phenotypers and healthy controls, independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2012;97(10):3709–16. This cross-section case control study investigated the differences in ectopic fat accumulations between hyperandrogenic PCOS, PCOS with normal androgens and healthy controls. The results suggested that hyperandrogenic PCOS is associated with hepatic steatosis, independent of obesity and insulin resistance presence.PubMed

74.

Valassi E, Crespo I, Santos A, Webb SM. Clinical consequences of Cushing’s syndrome. Pituitary. 2012;15(3):319–29.PubMed

75.

Bodelier AG, Groeneveld W, van der Linden A, Haak HR. Symptomatic epidural lipomatosis in ectopic Cushiung’s syndrome. Eur J Endocrinol. 2004;151(6):765–9.PubMed

76.•

Wang XJ, Wei DI, Song ZG, Jiao HC, Lin H. Effects of fatty acid treatments on the dexamethasone-induced intramuscular lipid accumulation in chickens. Plos ONE. 2012;7(5):e36663. The dexamethasone-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1(FAPT1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. Moreover, dexamethasone-stimulated lipid deposition was augmentated by palmitic acid supplementation, but alleviated by oleic acid, in response to pathways that were regulated differently, including AMPK, mTOR and FAPT1.PubMedCentralPubMed

77.

Geer EB, Shen W, Strohmayer E, Post KD, Freda PU. Body composition and cardiovascular risk markers after remission of Cushing’s Disease: a prospective study using whole-body MRI. J Clin Endocrinol Metab. 2012;97(5):1702–11.PubMedCentralPubMed

78.

Rockall AG, Sohaib SA, Evans D, et al. Hepatic steatosis in Cushing’s syndrome: a radiological assessment using computer tomography. Eur J Endocrinol. 2003;149(6):543–8.PubMed

79.•

Tarantino G, Finelli C. Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholoc fatty liver disease. World J Gastroenterol. 2013;19(40):6735–43. Overview of the literature related to hepatic steatosis, its prevalence, clinical consequences and, in particular, the pathogenesis of this disorder. The authors focus on the link between hypercorticolism and NAFLD, and try to explain the low prevalence of this complication in 50 newly diagnosed patients with Cushing’s syndrome by the anti-inflammatory effect of high circulating levels of glucocorticoids.PubMedCentralPubMed

80.

Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes. 1994;18:207–12.

81.

Fantin F, Di Francesco V, Fontana G, et al. Longitudinal body composition changes in old men and women: interrelationships with worsening disability. J Gerontol. 2007;62A:1375–81.

82.

Tchkonia T, Corkey BE, Kirkland JL. Current views of the fat cell as an endocrine cell: lipotoxicity. Endocrine Updates. 2003;26:105–18.

83.

Goodpaster BH, Carlson CL, Visser M, et al. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol. 2001;90:2157–65.PubMed

84.

Ryan AS, Nicklas BJ. Age-related changes in fat deposition in mid-thigh muscle in women: relationships with metabolic cardiovascular disease risk factors. Int J Obes Relat Metab Disord. 1999;23:126–32.PubMed

85.

Silaghi A, Piercecchi-Marti MD, Grino M, et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity. 2008;16:2424–30.PubMed

86.

Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age on hundred taking into account sex, obesity, and presence of type 2 diabetes. Clin Anat. 2007;20:933–42.PubMedCentralPubMed

87.

Cree MG, Newcomer BR, Katsanos CS, et al. Intramuscular and liver triglycerides are increased in the elderly. J Clin Endocrinol Metab. 2004;89:3864–71.PubMed

88.

Foster MC, Hwang SJ, Porter SA, et al. Fatty Kidney, Hypertension, and Chronic Kidney Disease: The Framingham Heart Study. Hypertension. 2011;58:784–90.PubMedCentralPubMed

89.

Kugel H, Jung C, Shulte O, Heindel W. Age-and sex-specific differences in the 1H-spectrum of vertebral bone marrow. J Magn Reson Imaging. 2001;13:263–8.PubMed

90.

Gimble JM, Robinson CE, Wu X, Kelly KA. The function of adipocytes in the bone marrow stroma: an update. Bone. 1996;19:421–8.PubMed

91.

Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol. 2006;2:35–43.PubMed

92.

Snel M, Jonker JT, Schoones J, et al. Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol. 2012;2012:983814.PubMedCentralPubMed

93.

Helibronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord. 2004;28(S4):S12–21.

94.

Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013;93:1–21.PubMed

95.

Mazzatti D, Lim FL, O’Hara A, Wood IS, Trayhurn P. A microarray analysis of the hypoxia-induced modulation of gene expression in human adipocytes. Arch Physiol Biochem. 2012;118:112–20.PubMed

96.

Unger RH. Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine. Biochimie. 2005;87:57–64.PubMed

97.

Unger RH, Scherer PE, Holland WL. Dichotomous roles of leptin and adiponectin as enforces against lipotoxicity during feast and famine. Mol Biol Cell. 2013;24:3011–5.PubMedCentralPubMed

98.

Simuzu H, Oh-I S, Okada S, Mori M. Leptin resistance and obesity. Endocrine J. 2007;54:17–26.

99.

Mantzoros CS, Magkos F, Brinkoetter M, et al. Leptin in human physiology and pathophysiology. Am J Endocrinol Metab. 2011;301(4):E567–84.

100.

Choi SH, Hong ES, Lim S. Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health. Front Endocrinol. 2013;21:1–7.

101.

Ortega FJ, Fernandez-Real JM. Inflammation in adipose tissue and fatty acid anabolism: when enough is enough! Horm Metab Res. 2013;45:1009–19.PubMed

102.

Sepe A, Tchkonia T, Thomou T, Zamboni M, Kirkland JL. Aging and regional differences in fat cell progenitors — a mini review. Gerontology. 2011;57:66.PubMed

Titel: Predictors of Ectopic Fat in Humans
verfasst von: Mauro Zamboni
Andrea P Rossi
Francesco Fantin
Simona L Budui
Elena Zoico
Giulia A Zamboni
Gloria Mazzali
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Current Obesity Reports / Ausgabe 4/2014
Elektronische ISSN: 2162-4968
DOI: https://doi.org/10.1007/s13679-014-0126-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Evaluating the Health Impacts of Food and Beverage Taxes

Food and Beverage Marketing to Youth

Androgens, body fat Distribution and Adipogenesis

Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome

Impact of Adiposity and Fat Distribution on the Dynamics of Adrenocorticotropin and Cortisol Rhythms